OHBM 2017 Annual Meeting is in Vancouver, Canada! Plan accordingly to ensure your submission is submitted before the deadline! For questions regarding the Call for Educational Courses and Symposia, or the Call for Abstracts, please contact Anne Beauclaire, Administrative & Meetings Coordinator, at. Note that the deadline for submissions is now December 15, 2016! With the increasing number of proposals being submitted, more time was needed for careful review and consideration of each proposal. The Call for Educational Courses, Symposia and Abstracts will be sent next week. I look forward to serving you, the OHBM membership, as the Council Chair this coming year.Įducational Course, Symposia & Abstract Earlier Deadline: December 15, 2016! We truly appreciate the enthusiasm, energy and outstanding research brought to the meeting. In this newsletter you will read about a change in location for our next Annual Meeting, learn about a new award, find out about the change in timing for abstract submission and get connected to what's being talked about in the brain mapping community through our many outreach efforts in social media, the Huffington Post and the OHBM blog. As always, the time together served as a chance to connect with others who share a common sense of purpose. We experienced beautiful weather in a city surrounded by mountains and still managed to have amazing attendance and participation (even overflowing at times) at the sessions and keynotes. New initiatives were announced and others were brought forward for consideration in the coming year.
#HUMAN BRAIN MAPPING 2016 FULL#
The OHBM Annual Meeting in Geneva was a busy week full of exciting science and bleeding-edge research, in-depth discussions and time spent identifying issues and challenges within the brain mapping community.
#HUMAN BRAIN MAPPING 2016 FREE#
Isoprostane quantification: Gas chromatography mass spectrometry (GC/MS) quantitation of isoprostanes to measure oxidative stress and to assess free radical injury.Protein quantification by Luminex: Luminex assays to assess protein levels of neuropathological and immune system targets, complementing measurements from traditional antibody-based (IHC) methods.RNA-Seq: RNA sequencing data for temporal cortex, parietal cortex, cortical white matter, and hippocampus isolated by macrodissection.In situ hybridization (ISH): High-resolution ISH image data of six canonical marker genes for astrocytes, oligodendrocytes, and neuronal subtypes in parietal cortex, temporal cortex, and hippocampus.Histology and immunohistochemistry (IHC): Image data and quantitative image metrics to assess β-amyloid, tau, and α-synuclein pathologies as well as the overall local pathological state of tissue samples from each donor.The Aging, Dementia and Traumatic Brain Injury Study includes the following data sets: All of those steps are initiated after contacting Overview Linking those data with other ACT study or Kaiser Permanente Washington data would require additional review. Data available from this study web site do not require any additional Institutional Review Board (IRB) approval or permissions. ACT is a repository at the Kaiser Permanente Washington Health Research Institute, which has established policies and procedures for sharing data with external investigators. The ACT study is a longitudinal population-based prospective cohort study of brain aging and incident dementia in the Seattle metropolitan area.
#HUMAN BRAIN MAPPING 2016 HOW TO#
Dirk Keene, University of Washington PI: Eric Larson, Kaiser Permanente Washington Health Research Institute and PI: Ed Lein, Allen Institute for Brain Science).Īdditional Data in the ACT Study and How to Access It Allen Family Foundation (PIs: Richard Ellenbogen and C. The Aging, Dementia and Traumatic Brain Injury Study was developed by a consortium consisting of the University of Washington, Kaiser Permanente Washington Health Research Institute and the Allen Institute for Brain Science. The Aging, Dementia and Traumatic Brain Injury Study is a detailed neuropathologic, molecular and transcriptomic characterization of brains of control and TBI exposure cases from a unique aged population-based cohort from the Adult Changes in Thought (ACT) study. Aging, Dementia and Traumatic Brain Injury Study
0 kommentar(er)
